京基智慧文化二零二三年中期报告

(Incorporated in the Cayman Islands and continued in Bermuda with limited liability) (Stock Code550) 2023Interim Report Contents目錄 Management Discussion and Analysis BUSINESS REVIEW Recruit Recruit Magazine 20192.9%3.0%2.9%1.2%1.1%17,000,0003,200,00023% The COVID-19 has begun to subside in late 2022. Hong Kong relaxedthe counter-epidemic measures and resumed the connections with thePeople’s Republic of China (the “PRC”) and overseas countries by re-opening its borders. The economic activities in Hong Kong have sincebeen recovering as evidenced by the increase in GDP of 2.9% in thefirst quarter of 2023. Labour market continues to improve alongsidethe economy recovery. The unemployment rate decreased from 3.0%for the period from March to May 2023 to 2.9% for the period fromApril to June 2023. And, the underemployment rate also decreasedfrom 1.2% to 1.1%. This shows that the labour market is getting hotwhere enterprises have the appetite back to hiring more staff, leadingto more recruitment advertisements were placed. As a result, for thesix months ended 30 June 2023, the revenue contributed from thisbusiness segment was approximately HK$17.0 million, representingan increase of approximately HK$3.2 million, or 23% from the sameperiod of last year. Medical and Health Services 2019Recruit2019400,00012,500,00097% As stated in our 2022 annual report, after three years of devastationof the COVID-19 pandemic, it finally has come to an end. Althoughit has resulted a positive effect on our Recruit Magazine business,it adversely affected our Medical and Health Services business. Forthe six months ended 30 June 2023, the revenue from this businessdecreased significantly to only approximately HK$0.4 million, or 97%compared with last year’s approximately HK$12.5 million of the sameperiod due to the significant decrease in demand of our COVID-19test kits and related medical advisory services. E-Commerce 2,900,000200,0007% For the six months ended 30 June 2023, the revenue contributed fromthis business segment was approximately HK$2.9 million, representingan increase of approximately HK$0.2 million, or 7% from the sameperiod of last year. Performance of this business was steady. Management Discussion and Analysis管理層討論與分析 Other Investments As disclosed in our 2022 annual report, the Company has madeinvestments in concerts of several popular pop song artists. As at thereporting date, total of three artists’ concerts were invested eventuallyand two of them had held in the first half of this year which provedthat the Company managed to make a right decision by riding onthe back of the re-opening of the borders that people are eager forentertainments which they have been longing for in the past fewyears. Both of them recorded a double-digit positive annualised return.The remaining concert is scheduled to be held in the four quarter ofthis year. None of the investments exceeded 5% of any applicableratios and, accordingly, disclosures by way of announcement, circularand shareholders’ approval were exempt. 5% 2,100,000 On the other hand, however, the investment in a medical business inthe PRC as an associate has started operation to a limited extent asat 30 June 2023. As a result, it was loss making and the Companyshared a loss of approximately HK$2.1 million. PROSPECTS 2019Recruit Following the resumption to normal from the COVID-19 pandemicin early March, Hong Kong’s economic activities are recovering bitby bit where the labour market is back to active. We expect that thedemand for recruitment advertising will still be keen for the rest of thisyear and our Recruit business will perform satisfactorily accordingly.Regarding the E-Commerce business, we expect it will outperformlast year because in the second half of 2023, the purchase order wehave received already exceeded the total amount recorded in lastyear in dollar terms. This shows that prospect of this business is stillconsiderably positive. As for the Medical and Health Services business,however, we believe that, after the dying down of the pandemic, thisbusiness will continue to decrease to a minimal level. FINANCIAL REVIEW 20,200,00029,000,0008,800,00030%20192019 For the six months ended 30 June 2023, the Group recordedrevenue of approximately HK$20.2 million (2022: HK$29.0 million)representing a decrease of approximately HK$8.8 million or 30%. Thedecrease was mainly due to end of the COVID-19 counter-epidemicmeasures, demand of COVID-19 test kits and related services wasdecreased which led to a fall in revenue from Medical and HealthServices business. Management Discussion and Analysis Selling and distribution costs increased from approximately HK$4.2million in the first half of 2022 to approximately HK$6.2 million in thefirst half of 2023. More marketing activities were provided to capturethe business opportunity. 4,200,0006,200,000 16,400,00012,300,0004,100,00033% For the six months ended 30 June 2023, the Group recordedapproximately HK$1